NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Sees Large Growth in Short Interest

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 11,100 shares, an increase of 825.0% from the June 30th total of 1,200 shares. Based on an average daily volume of 11,200 shares, the short-interest ratio is presently 1.0 days.

NLS Pharmaceutics Stock Performance

Shares of NLSPW remained flat at $0.04 during midday trading on Thursday. The stock had a trading volume of 3 shares, compared to its average volume of 14,443. NLS Pharmaceutics has a one year low of $0.01 and a one year high of $0.17. The company’s 50 day moving average price is $0.04 and its two-hundred day moving average price is $0.05.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).